Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

An exploratory Phase 1/2 clinical study evaluating the safety and efficacy of CAR-T cell therapy for relapsed/refractory myeloid malignancies, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• CAR-T cell therapy (experimental) (CAR-T cell therapy)

Snippet

Sponsor: Tongji Hospital | Conditions: Myeloid Malignancies, CAR-T | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING